BNET Industries

Last Fiscal Year Sales:$10.0B
  • Public
  • JP
Dow Jones Description

Takeda promises better living through chemicals. Founded in 1781 and headquartered in Osaka, Japan, Takeda Pharmaceutical Company Limited is Japan's largest drug maker. The company, besides making pharmaceutical products, also offers vitamins, food additives, and some chemicals. It is developing drugs for a range of diseases and conditions. The company has annual revenues of about $10.4 billion and employs about 14,500 people. It recently announced plans to acquire Syrrx in order to start an R&D operation in the US.

Chairman & CEO
Kunio Takeda
Number of Employees 15,717
Contact Information

1-1 Doshomachi 4-Chome

Chuo-Ku

Osaka 540 8645

www.takeda.com

(81) 6 6204 2111

NAICS Code Frozen Fruit, Juice, and Vegetable Manufacturing: 311411

Recent Events

  • Domain Therapeutics announces successful completion of the first milestone in its Research Agreement with Takeda...

    11/04/09 - Joint Venture / Alliance - View Story

  • Japan co Takeda Pharma licenses US co Amylin for obesity drug

    11/04/09 - Licensing / Contract - View Story

  • Market Report -- In Play AMLN

    11/02/09 - Joint Venture / Alliance - View Story

  • Pharmaceuticals see proposed health care legislation as mixed bag

    11/07/09 - Joint Venture / Alliance - View Story

  • Takeda Pharma H1 Profit Soars; Updates FY09 Forecast - Update

    10/30/09 - Stock Split / Dividend - View Story

  • Strong Yen Hits Drug Firms

    11/01/09 - Financial Announcement - View Story

  • Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...

    10/14/09 - Mgmt. Change Entering - Vice President - View Story

  • Takeda San Francisco Enters Into A Sponsored Research Agreement With University of California, San Francisco...

    9/22/09 - Joint Venture / Alliance - View Story

  • Sepracor vows to stay in Mass.

    9/04/09 - Licensing / Contract - View Story

  • Dainippon Agrees to Buy Sepracor

    9/04/09 - Merger / Acquisition - View Story

  • Takeda to start key diabetes drug trial in Sept

    8/28/09 - Bond / Stock Rating - View Story

  • Alnylam Q2 net loss widens

    8/11/09 - Financial Announcement - View Story

  • UPDATE 1-Japan's Takeda to buy IDM Pharma in cancer drug push

    5/18/09 - Merger / Acquisition - View Story

News & Analysis

takeda pharmaceutical company ltd. - All News and Analysis

Decision Makers

Name (plus bio) Position
Alan Mackenzie President
Hiroshi Ohtsuki President, Consumer Healthcare
Yasuchika Hasegawa President & COO
Hiroshi Akimoto Managing Director
Hiroshi Shinha General Manager, Legal Dept
Hiroshi Takahara General Manager, Finance & Accounting Dept
Kazuaki Ikeya General Manager, Strategic Product Planning
Kiyoshi Kitazawa General Manager, Pharmaceutical Development Division
Makoto Yamaoka Managing Director & General Manager, Pharmaceutical Marketing Division
Naohisa Takeda General Manager, Europe & Asia
Toyoji Yoshida General Manager, Corp Communs Dept
Tsutomu Miura General Manager, Ethical Products Marketing Dept
Yasuhiko Yamanaka General Manager, Corp Strategy & Planning

Board of Directors

Name (plus bio) Position
Kunio Takeda Chairman & CEO
James L. Tyree Board of Directors
Takshi Soda Board of Directors

Organization Position Status
Takeda Pharmaceutical Company Limited Chairman & CEO Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited President Current

Organization Position Status
Takeda Pharmaceutical Company Limited President, Consumer Healthcare Current

Organization Position Status
Takeda Pharmaceutical Company Limited President & COO Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited Managing Director Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Legal Dept Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Finance & Accounting Dept Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Strategic Product Planning Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Pharmaceutical Development Division Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited Managing Director & General Manager, Pharmaceutical Marketing Division Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Europe & Asia Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Corp Communs Dept Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Ethical Products Marketing Dept Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Corp Strategy & Planning Current

James Tyree is senior vice president, Pharmaceutical Operations Tyree first joined Abbott from 1978 until 1979 as a business analyst for a year. He rejoined the company in June 1997 and has been in various management positions including divisional vice president and general manager for Abbott's international division in Japan. He recently served as vice president, global licensing/new business development in the Pharmaceutical Products Division. He assumed his current role in 2006. Prior to re-joining Abbott in 1997, Tyree was president of Sugen Inc., a biotechnology start-up company and held various leadership positions at other pharmaceutical companies. He serves on the board of directors for TAP Pharmaceuticals, a joint venture between Abbott and Takeda Pharmaceutical Company Limited. He is a member of the advisory boards of the Polsky Center of Entrepreneurship at the University of Chicago and the Kellogg Center for Biotechnology at Northwestern University. He is a member of Richard M. Daley's Chicago Mayor's Council of Technology Advisors. Formerly chairman, he is also chairman of the board of directors of the Illinois Biotechnology Industry Organization. He earned bachelor's degrees in psychology and forensic studies and a master's degree in business administration from Indiana University.

Organization Position Status
Northwestern University Member Current
University of Chicago Member Current
Kellogg Company Member Current
Takeda Pharmaceutical Company Limited Board of Directors Current
Indiana University Master's Degree In Business Administration Former

Organization Position Status
Takeda Pharmaceutical Company Limited Board of Directors Current

Executive News

  • UPDATE 1-Japan's Takeda to buy IDM Pharma in cancer drug push

    Forbes.com - 5/18/09 - View Story

  • UPDATE 1-Japan's Takeda to buy IDM Pharma in cancer drug push

    Reuters - 5/18/09 - View Story

  • Takeda Posts 34% Profit Drop

    The Wall Street Journal Interactive Edition - 5/11/09 - View Story